| Gene symbol | LAMP3 | Synonyms | CD208, DC LAMP, DC-LAMP, DCLAMP, LAMP, LAMP-3, TSC403 | Type of gene | protein-coding |
| Chromosome | 3 | Map location | 3q27.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | lysosomal associated membrane protein 3 | ||||
| Gene symbol | UL83 | Synonyms | None | Type of gene | protein-coding |
| Chromosome | - | Map location | NC_006273.2 | dbXrefs | |
| Description | tegument protein pp65 | ||||
| GTO ID | GTC1537 |
| Trial ID | NCT02465268 |
| Disease | Glioblastoma | Astrocytoma |
| Altered gene | UL83|LAMP |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | mRNA vaccine |
| Treatment | pp65 DC |
| Phase | Phase2 |
| Recruitment status | Active, Not Recruiting |
| Title | A Phase II Randomized, Blinded, and Placebo-controlled Trial of CMV RNA-Pulsed Dendritic Cells With Tetanus-Diphtheria Toxoid Vaccine in Patients With Newly-Diagnosed Glioblastoma |
| Year | 2016 |
| Country | United States |
| Company sponsor | Immunomic Therapeutics, Inc. |
| Other ID(s) | IRB201400697-N|R01CA175517|OCR14127 |
| Vector information | |||
|
|||
| Cohort1: pp65-shLAMP DC with GM-CSF | |||||
|
|||||
| Cohort2: unpulsed PBMC and saline | |||||
|
|||||